Nirgundyadi Kashaya orally and Nalpamara Kashaya Prakshalana in Kaphaja Yonivyapada

Clinical Study to evaluate the efficacy of Nirgundyadi Kashaya orally and Nalpamara Kashaya prakshalana in Kaphaja Yonivyapada

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030489

Enrollment

Registered

2021-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: NIRGUNDYADI KASHAYA ORALLY AND NALPAMARA KASHAYA PRAKSHALANA: NIRGUNDYADI KASHAYA ORALLY 40 ML TWICE DAILY FOR (60+15 DAYS) AND NALPAMARA KASHAYA 500 ML FOR YONI PRAKSHALANA FOR 15 MINU

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married females 2 Patients with complaints of white discharge per vaginum(Pandu varna srava) 3 Itching(Kandu) 4 Unctuousness in genitalia(Pichhilata) 5 Pain in vulva and vagina(Alpa Vedana)

Exclusion criteria

Exclusion criteria: 1 Unmarried 2 Pregnant women 3 Patients suffering from systemic diseases like TB, DM, Bronchial Asthma, Jaundice, Cardiovascular disease, renal problems 4 Patient having history of any drug allergy and psychological disorders 5 Patients having any specific pathology of genital tract i.e. benign or malignant tumor, tubo-ovarian abscess, erosion of cervix, acute pelvic inflammatory disease 6 Patients suffering from any disease of external genital organs like any boil, infected cyst, bartholin gland abscess or any skin disease like eczema 7 Patients who canâ??t attend follow up regularly 8 Patient not giving consent to participation in the study 9 Patient who is participating in any other research study

Design outcomes

Primary

Measure	Time frame
Assessment will be done on the basis of prepared proforma and improvement in sign and symptoms of kaphaja yonivyapadaTimepoint: Oral administration of Nirgundyadi Kashaya 40 ml in morning and evening after meal for 60 day. 5 follow-up will be done at every 15 days. Four follow-ups with medication and last follow-up will be done without medication. Prakshalana of vagina with 500 ml (Approx.) of Nalpamara Kashaya will be done for about 15 minutes once a day for 7 days in post-menstrual period for two consecutive months.	—

Measure

Time frame

Assessment will be done on the basis of prepared proforma and improvement in sign and symptoms of kaphaja yonivyapadaTimepoint: Oral administration of Nirgundyadi Kashaya 40 ml in morning and evening after meal for 60 day. 5 follow-up will be done at every 15 days. Four follow-ups with medication and last follow-up will be done without medication. Prakshalana of vagina with 500 ml (Approx.) of Nalpamara Kashaya will be done for about 15 minutes once a day for 7 days in post-menstrual period for two consecutive months.

—

Secondary

Measure	Time frame
Improvement in criteria listed in different scales.Timepoint: Oral administration of Nirgundyadi Kashaya 40 ml in morning and evening after meal for 60 day. 5 follow-up will be done at every 15 days. Four follow-ups with medication and last follow-up will be done without medication. Prakshalana of vagina with 500 ml (Approx.) of Nalpamara Kashaya will be done for about 15 minutes once a day for 7 days in post-menstrual period for two consecutive months.	—

Measure

Time frame

Improvement in criteria listed in different scales.Timepoint: Oral administration of Nirgundyadi Kashaya 40 ml in morning and evening after meal for 60 day. 5 follow-up will be done at every 15 days. Four follow-ups with medication and last follow-up will be done without medication. Prakshalana of vagina with 500 ml (Approx.) of Nalpamara Kashaya will be done for about 15 minutes once a day for 7 days in post-menstrual period for two consecutive months.

—

Countries

India

Contacts

Public ContactDr Smita Chaurasia

Banaras Hindu University

vishweshbn@gmail.com8277033135

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026